Abstract
Background and purpose: To characterize local control and late toxicity in long-term survivors prospectively-treated with spine stereotactic radiosurgery (SSRS). Materials and methods: From 2002 to 2011, 228 patients were prospectively-treated on protocol for metastatic disease of 261 vertebral sites. A subset of 52 patients surviving >4 years following treatment were collectively treated for 58 sites (encompassing 69 vertebrae) and underwent secondary analysis. Of all sites, 9% received prior radiation, and 16% encompassed multiple contiguous vertebrae. Radiation prescriptions were most commonly 24 Gy in 1 and 27 Gy in 3 fractions. Outcomes were evaluated via Kaplan–Meier, and associations analyzed via logistic regression. Results: Median follow-up was 6.7 years (range: 49–142 months). Five-year local control by site was 91%, with late failures (>2 years) occurring in 3%. Overall and Grade ≥3 late toxicities (>2 years) were observed in 5% and 2% of sites. The last known neurologic event (grade 2 radiculopathy) was noted 2.1 years post-treatment, while the last documented fracture occurred at 4.1 years. No Grade ≥3 events were witnessed after 3.1 years post-SSRS, and no toxicities were noted after 4.1 years through end of follow-up. Re-irradiation, number of segments treated per site (1 vs. 2–3), and fractionation (1 vs. 3–5) were not associated with failure or toxicity. Conclusion: SSRS maintains excellent disease control and a favorable late toxicity profile even among long-term survivors, with very few failures or toxicities after 2 years in this prospectively-treated population. Overall, these data support the durable control and long-term safety of SSRS with extended follow-up.
Original language | English (US) |
---|---|
Pages (from-to) | 80-85 |
Number of pages | 6 |
Journal | Radiotherapy and Oncology |
Volume | 138 |
DOIs | |
State | Published - Sep 2019 |
Keywords
- Bone
- Fractures
- Radiosurgery
- Spinal cord injuries
- Spinal metastases
- Survivorship
ASJC Scopus subject areas
- Hematology
- Oncology
- Radiology Nuclear Medicine and imaging